3 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 3, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1 |
Follow Clinical Trial: new trials by email Literature Review of Clinical Trial trials Research Report on Clinical Trial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen. Botulinum Toxin A, CONTROL - Botulinum Toxin Type A, Open Abdomen | Phase 4 | Not yet recruiting | Instituto de Investigación Hospital Universitario La Paz | 50 | 2025-01-01 | 2024-08-15 |
| Optimal Dosage of Melatonin for Preoperative Sedation in FESS Melatonin - Clinical Trial | Phase 4 | Completed | Aswan University Hospital | 160 | 2024-08-01 | 2026-04-24 |
| Role of Strontium Ranelate in Proximal Femur Fragility Fractures. Strontium Ranelate, Lacto-N-Hexaose - Fragility Fracture, Femur; Fracture, Pertrochanteric | Phase 4 | Unknown | Aga Khan University Hospital, Pakistan | 100 | 2021-11-01 | 2023-02-03 |
| Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome Evolocumab, NIRS IVUS - Clinical Trial, Acute Coronary Syndrome | Phase 4 | Unknown | Korea University Anam Hospital | 60 | 2021-03-01 | 2023-10-05 |
| GOREISAN for Heart Failure (GOREISAN-HF) Trial Goreisan, Standard Treatment - Heart Failure, Edema | Phase 4 | Active not recruiting | Takeshi Morimoto | 1179 | 2021-01-19 | 2026-01-06 |
| Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae Meropenem, Ertapenem 1000 MG, Piperacillin, Tazobactam 4-0.5G Solution for Injection - Urinary Tract Infections, Enterobacteriaceae Infections | Phase 4 | Suspended | Universidad del Norte | 198 | 2019-04-01 | 2024-12-06 |
| Effect of Fluvastatin on Brown Fat Activity Fluvastatin - Adipose Tissue, Brown, Insulin Resistance | Phase 4 | Completed | University of Zurich | 17 | 2017-05-31 | 2018-05-31 |
| BONDING TO ENAMEL USING A UNIVERSAL ADHESIVE 1-step self-etch approach (SE), selective enamel etching (SEE), 1-step self-etch for double time (SE2X) - Clinical Trial | Phase 4 | Completed | Universidade Estadual de Ponta Grossa | 35 | 2016-02-01 | 2017-08-29 |
Acute Coronary Syndrome (1) · Edema (1) · Enterobacteriaceae Infections (1) · Escherichia coli Infections (1) · Fractures, Bone (1) · Heart Failure (1) · Insulin Resistance (1) · Urinary Tract Infections (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Gram-Negative Bacterial Infections (1) · Hyperinsulinism (1) · Infections (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
Botulinum Toxins, Type A (1) · Ertapenem (1) · Fluvastatin (1) · Injections (1) · Lactose (1) · Melatonin (1) · Meropenem (1) · Piperacillin (1) · Solutions (1) · Tazobactam (1) · evolocumab (1) · lacto-N-hexaose (1) · oryeongsan (1) · strontium ranelate (1)
Aga Khan University Hospital, Pakistan (1) · Aswan University Hospital (1) · Instituto de Investigación Hospital Universitario La Paz (1) · Korea University Anam Hospital (1) · Takeshi Morimoto (1) · Universidad del Norte (1) · Universidade Estadual de Ponta Grossa (1) · University of Zurich (1)
Brazil (1) · Colombia (1) · Egypt (1) · Japan (1) · Pakistan (1) · South Korea (1) · Switzerland (1)
Andres F Estupinan Bohorquez, MD (1) · Diego F Viasus Perez, MD. PhD. (1) · Irene A Burger, M.D. (1) · Luis Asensio Gomez, Consultant (1) · Rafael Scheffer, Master (1) · Takeshi Kimura, MD, PhD (1) · Victor Vaello Jodra, Consultant (1)